glp 1 agonist cardioprotective The Potential Role of GLP-1 Analogues in Cardiovascular Disease O EASD 2018: benefits of GIP/GLP-1
Description
Do not reuse
Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity
Obesity is a chronic disease associated with increased risk of obesity-related complications and mortality
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach
Learn about the latest science behind GLP-1 weight loss drugs, the nutritional needs of GLP-1 users and what this means for future innovation in food and beverage.
Aids sustainable weight management
